PTCA An Investigational Tool and a Non-Operative Treatment of Acute Ischemia

• One: An Investigational Tool.- From in-vitro to in-vivo model.- 1. Myocardial ischemia: Early adjustment and reversibility.- 2. Early changes in wall thickness and epicardial wall motion during percutaneous transluminal coronary angioplasty in man: Similarities with in-vitro and in-vivo model.- 3. Early mechanical changes associated with coronary artery Occlusion.- Electrocardiographic changes.- 4. Coronary angiographic and hemodynamic determinants of ST-segment response to acute coronary occlusion.- 5. Dynamic appearance of collaterals during coronary occlusion and their impact on electrocardiographic changes and wall motion abnormalities.- Role of collaterals during PTCA.- 6. Collaterals and coronary wedge pressure.- Coronary flow and flow reserve.- 7. Intracoronary blood flow velocity, reactive hyperemia and coronary blood flow reserve during and following PTCA.- Myocardial metabolism.- 8. Loss of hydrogen and potassium ions after short periods of myocardial ischaemia in man.- 9. Myocardial release of hypoxanthine and lactate during coronary angioplasty: A quickly reversible phenomenon, but for how long?.- 10. Myocardial release of hypoxanthine and urate during angioplasty: Potential mechanism for free radical generation.- 11. Regional myocardial nitrogen-13-glutamate uptake following successful coronary angioplasty.- Myocardial function.- 12. Left atrial function in acute transient ischemia on the left ventricle.- 13. Left ventricular filling during acute ischemia.- 14. Left ventricular function during acute coronary artery balloon occlusion in humans.- 15. Use of intravenous DSA in the assessment of LV performance during PTCA.- 16. Two dimensional echocardiography during PTCA.- 17. Doppler echocardiographic assessment of left ventricular function during PTCA.- 18.Ejection filling and diastasis during transluminal occlusion in man: Consideration on global and regional left ventricular function.- Therapeutic effects.- 19. Myocardial ischemia during PTCA: Consequences and treatment strategies.- 20. Does Diltiazem protect the ischemic myocardium during PTCA?.- 21. Influence of anti-ischemic drug treatment on the ischemic response to acute coronary occlusion in man.- 22. Cardioprotective effects of coronary sinus retroperfusion during LAD angioplasty.- Two: Non-Operative Treatment of Acute Ischemia.- 23. Coronary angioplasty for unstable angina pectoris.- 24. Coronary angioplasty in patients with non-Q wave myocardial infarction.- 25. Thrombolytic therapy and PTCA in acute myocardial thrombosis.- 26. The United States thrombolysis and angioplasty trials for acute myocardial infarction.

'... durch die hervorragende Aufmachung and ubersichtliche Gestaltung. Fur jeden Kardiologen und Herzchirurgen ein unentbehrliches Werk, das den neuesten Stand dieser Behandlungsmethode aufzeigt.' Herz/Kreislauf, 23/1, 1991